From: Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
CTC HER2
Tumor tissue HER2
Total
+
-
3+ >30%
13
0
3+ ≤30%
14
9
23
27
36